Non-alcoholic fatty liver disease

The Lancet

Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial

Bruce Cree, Jeffrey L. Bennett et al. 2019-09-05 · Read paper → The Lancet

Management of functional somatic syndromes

Peter Henningsen, Stephan Zipfel, Wolfgang Herzog 2007-02-07 · Read paper → The Lancet

Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial

Gerhard Hindricks, Miloš Táborský et al. 2014-08-01 · Read paper → The Lancet

Cardiovascular remodelling in coronary artery disease and heart failure

Gerd Heusch, Peter Libby et al. 2014-05-01 · Read paper → The Lancet

Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial

Usha Menon, Aleksandra Gentry‐Maharaj et al. 2021-05-12 · Read paper → The Lancet

Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis

Juan Pablo Casas, Weiliang Chua et al. 2005-12-01 · Read paper → The Lancet

The Lancet Commission on ending stigma and discrimination in mental health

Graham Thornicroft, Charlene Sunkel et al. 2022-10-01 · Read paper → The Lancet

Tobacco use in 3 billion individuals from 16 countries: an analysis of nationally representative cross-sectional household surveys

Gary A. Giovino, Sara A. Mirza et al. 2012-08-01 · Read paper → The Lancet

Hypertension in developing countries

M. Mohsen Ibrahim, Albertino Antonio Moura Damasceno 2012-08-01 · Read paper → The Lancet

Intracerebral haemorrhage: current approaches to acute management

Charlotte Cordonnier, Andrew M. Demchuk et al. 2018-10-01 · Read paper → The Lancet

Neurodevelopmental outcome at 5 years of age after general anaesthesia or awake-regional anaesthesia in infancy (GAS): an international, multicentre, randomised, controlled equivalence trial

Mary Ellen McCann, Jurgen C. de Graaff et al. 2019-02-01 · Read paper → The Lancet

Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial

Raymond R. Townsend, Felix Mahfoud et al. 2017-08-28 · Read paper →